Hoth Therapeutics Inc
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
RKTO$0.38-3.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 2023 and 2022
Consolidated Balance Sheets
| December 31, 2023 | December 31, 2022 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash | $9,292,352 | $6,428,611 |
| Marketable equity securities, at fair value | — | 209,320 |
| Prepaid expenses and other current assets | 135,361 | 88,450 |
| Total current assets | 9,427,713 | 6,726,381 |
| Right of use asset – operating lease | 55,165 | — |
| Investment in joint ventures at fair value | 37,400 | 33,000 |
| Total assets | $9,520,278 | $6,759,381 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $35,592 | $694,989 |
| Accrued expenses | 614,226 | 667,742 |
| Accrued license fee - current portion | — | 25,000 |
| Lease liability, current | 28,839 | — |
| Total current liabilities | 678,657 | 1,387,731 |
| Lease liability, noncurrent | 26,326 | — |
| Accrued license fee - less current portion | — | 250,000 |
| Total liabilities | 704,983 | 1,637,731 |
| Commitments and Contingencies (See Note 7) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized; 3,000,000 shares undesignated; 0 shares issued and outstanding as of December 31, 2023 and December 31, 2022 | — | — |
| Series A Convertible Preferred Stock, $0.0001 par value, 5,000,000 shares designated; 0 shares issued and outstanding at December 31, 2023 and December 31, 2022 | — | — |
| Series B Preferred Stock, $0.0001 par value, 2,000,000 shares designated; 0 shares issued and outstanding as of December 31, 2023 and December 31, 2022 | — | — |
| Common stock, $0.0001 par value, 50,000,000 shares authorized, 4,348,129 and 1,302,113 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively | 435 | 130 |
| Additional paid-in capital | 61,732,106 | 50,198,630 |
| Accumulated deficit | (52,944,506) | (45,099,116) |
| Accumulated other comprehensive income | 27,260 | 22,006 |
| Total stockholders’ equity | 8,815,295 | 5,121,650 |
| Total liabilities and stockholders’ equity | $9,520,278 | $6,759,381 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.